METAHYDRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metahydrin, and what generic alternatives are available?
Metahydrin is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in METAHYDRIN is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METAHYDRIN?
- What are the global sales for METAHYDRIN?
- What is Average Wholesale Price for METAHYDRIN?
Summary for METAHYDRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| DailyMed Link: | METAHYDRIN at DailyMed |
US Patents and Regulatory Information for METAHYDRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | METAHYDRIN | trichlormethiazide | TABLET;ORAL | 012594-001 | Jun 16, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Sanofi Aventis Us | METAHYDRIN | trichlormethiazide | TABLET;ORAL | 012594-002 | Jun 16, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
